Moderna Falls From Record as Euphoria of Vaccine Data Wears Off

(Bloomberg) -- Moderna Inc. shares fell from an all-time high as investors digested early data from a small trial of the company’s coronavirus vaccine, and a $1.3 billion stock sale announced late ...